Panagora Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,132
| Closed | -$200K | – | 1434 |
|
|
2023
Q1 | $200K | Sell |
15,132
-67,251
| -82% | -$888K | ﹤0.01% | 1381 |
|
|
2022
Q4 | $1.24M | Buy |
82,383
+18,914
| +30% | +$284K | 0.01% | 805 |
|
|
2022
Q3 | $749K | Buy |
63,469
+10,446
| +20% | +$123K | 0.01% | 978 |
|
|
2022
Q2 | $599K | Buy |
53,023
+5,563
| +12% | +$62.8K | ﹤0.01% | 1096 |
|
|
2022
Q1 | $1.42M | Buy |
47,460
+2,259
| +5% | +$67.5K | 0.01% | 801 |
|
|
2021
Q4 | $1.2M | Sell |
45,201
-377
| -0.8% | -$9.99K | 0.01% | 834 |
|
|
2021
Q3 | $1.65M | Sell |
45,578
-16,528
| -27% | -$600K | 0.01% | 762 |
|
|
2021
Q2 | $2.7M | Sell |
62,106
-59,839
| -49% | -$2.6M | 0.01% | 618 |
|
|
2021
Q1 | $4.17M | Buy |
121,945
+16,467
| +16% | +$563K | 0.02% | 518 |
|
|
2020
Q4 | $3.69M | Buy |
105,478
+2,251
| +2% | +$78.8K | 0.02% | 502 |
|
|
2020
Q3 | $2.48M | Buy |
103,227
+7,378
| +8% | +$177K | 0.02% | 561 |
|
|
2020
Q2 | $1.75M | Buy |
95,849
+5,535
| +6% | +$101K | 0.01% | 719 |
|
|
2020
Q1 | $1.41M | Sell |
90,314
-15,964
| -15% | -$249K | 0.01% | 717 |
|
|
2019
Q4 | $2.27M | Buy |
106,278
+57,270
| +117% | +$1.23M | 0.01% | 734 |
|
|
2019
Q3 | $916K | Buy |
49,008
+48,560
| +10,839% | +$908K | ﹤0.01% | 1052 |
|
|
2019
Q2 | $12K | Buy |
+448
| New | +$12K | ﹤0.01% | 2374 |
|
|
2017
Q1 | – | Sell |
-14,958
| Closed | -$356K | – | 2440 |
|
|
2016
Q4 | $356K | Sell |
14,958
-412
| -3% | -$9.81K | ﹤0.01% | 1564 |
|
|
2016
Q3 | $564K | Buy |
15,370
+519
| +3% | +$19K | ﹤0.01% | 1405 |
|
|
2016
Q2 | $331K | Buy |
14,851
+2,092
| +16% | +$46.6K | ﹤0.01% | 1492 |
|
|
2016
Q1 | $265K | Buy |
12,759
+1,223
| +11% | +$25.4K | ﹤0.01% | 1565 |
|
|
2015
Q4 | $349K | Buy |
11,536
+2,254
| +24% | +$68.2K | ﹤0.01% | 1437 |
|
|
2015
Q3 | $229K | Buy |
9,282
+8,039
| +647% | +$198K | ﹤0.01% | 1564 |
|
|
2015
Q2 | $40K | Buy |
+1,243
| New | +$40K | ﹤0.01% | 2193 |
|